Patents Assigned to Genome Therapeutics Corporation
  • Patent number: 7285400
    Abstract: The present invention relates to methods and materials used to isolate and detect a high bone mass gene and a corresponding wild-type gene, and mutants thereof. The present invention also relates to the high bone mass gene, the corresponding wild-type gene, and mutants thereof. The genes identified in the present invention are implicated in bone development. The invention also provides nucleic acids, including coding sequences, oligonucleotide primers and probes, proteins, cloning vectors, expression vectors, transformed hosts, methods of developing pharmaceutical compositions, methods of identifying molecules involved in bone development, and methods of diagnosing and treating diseases involved in bone development. In preferred embodiments, the present invention is directed to methods for treating, diagnosing and preventing osteoporosis.
    Type: Grant
    Filed: December 10, 2003
    Date of Patent: October 23, 2007
    Assignees: Genome Therapeutics Corporation, Creighton University
    Inventors: John P. Carulli, Randall D. Little, Robert R. Recker, Mark L. Johnson
  • Publication number: 20070037163
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Staphylococcus epidermidis that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
    Type: Application
    Filed: July 30, 2004
    Publication date: February 15, 2007
    Applicant: Genome Therapeutics Corporation
    Inventors: Lynn Doucette-Stamm, David Bush
  • Publication number: 20070020624
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Pseudomonas aeruginosa that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
    Type: Application
    Filed: April 21, 2003
    Publication date: January 25, 2007
    Applicant: GENOME THERAPEUTICS CORPORATION
    Inventors: Marc Rubenfield, Jork Nolling, Craig Deloughery, David Bush
  • Patent number: 7041814
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Enterobacter cloacae that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
    Type: Grant
    Filed: February 18, 1999
    Date of Patent: May 9, 2006
    Assignee: Genome Therapeutics Corporation
    Inventors: Keith G. Weinstock, Craig Deloughery, David Bush
  • Publication number: 20050142617
    Abstract: The present invention relates to methods and materials used to isolate and detect a high bone mass gene and a corresponding wild-type gene, and mutants thereof. The present invention also relates to the high bone mass gene, the corresponding wild-type gene, and mutants thereof. The genes identified in the present invention are implicated in bone development. The invention also provides nucleic acids, including coding sequences, oligonucleotide primers and probes, proteins, cloning vectors, expression vectors, transformed hosts, methods of developing pharmaceutical compositions, methods of identifying molecules involved in bone development, and methods of diagnosing and treating diseases involved in bone development. In preferred embodiments, the present invention is directed to methods for treating, diagnosing and preventing osteoporosis.
    Type: Application
    Filed: April 29, 2004
    Publication date: June 30, 2005
    Applicants: Genome Therapeutics Corporation, Creighton University School of Medicine
    Inventors: John Carulli, Randall Little, Robert Recker, Mark Johnson
  • Patent number: 6800744
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Streptococcus pneumonia that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
    Type: Grant
    Filed: June 30, 1998
    Date of Patent: October 5, 2004
    Assignee: Genome Therapeutics Corporation
    Inventors: Lynn A. Doucette-Stamm, David Bush
  • Publication number: 20040176582
    Abstract: The present invention relates to methods and materials used to isolate and detect a high bone mass gene and a corresponding wild-type gene, and mutants thereof. The present invention also relates to the high bone mass gene, the corresponding wild-type gene, and mutants thereof. The genes identified in the present invention are implicated in bone development. The invention also provides nucleic acids, including coding sequences, oligonucleotide primers and probes, proteins, cloning vectors, expression vectors, transformed hosts, methods of developing pharmaceutical compositions, methods of identifying molecules involved in bone development, and methods of diagnosing and treating diseases involved in bone development. In preferred embodiments, the present invention is directed to methods for treating, diagnosing and preventing osteoporosis.
    Type: Application
    Filed: December 10, 2003
    Publication date: September 9, 2004
    Applicants: Genome Therapeutics Corporation, Creighton University
    Inventors: John P. Carulli, Randall D. Little, Robert R. Recker, Mark L. Johnson
  • Patent number: 6780609
    Abstract: The present invention relates to methods and materials used to isolate and detect a high bone mass gene and a corresponding wild-type gene, and mutants thereof. The present invention also relates to the high bone mass gene, the corresponding wild-type gene, and mutants thereof. The genes identified in the present invention are implicated in bone development. The invention also provides nucleic acids, including coding sequences, oligonucleotide primers and probes, proteins, cloning vectors, expression vectors, transformed hosts, methods of developing pharmaceutical compositions, methods of identifying molecules involved in bone development, and methods of diagnosing and treating diseases involved in bone development. In preferred embodiments, the present invention is directed to methods for treating, diagnosing and preventing osteoporosis.
    Type: Grant
    Filed: April 5, 2000
    Date of Patent: August 24, 2004
    Assignee: Genome Therapeutics Corporation
    Inventors: John P. Carulli, Randall D. Little, Robert R. Recker, Mark L. Johnson
  • Patent number: 6770461
    Abstract: The present invention relates to methods and materials used to isolate and detect a high bone mass gene and a corresponding wild-type gene, and mutants thereof. The present invention also relates to the high bone mass gene, the corresponding wild-type gene, and mutants thereof The genes identified in the present invention are implicated in bone development. The invention also provides nucleic acids, including coding sequences, oligonucleotide primers and probes, proteins, cloning vectors, expression vectors, transformed hosts, methods of developing pharmaceutical compositions, methods of identifying molecules involved in bone development, and methods of diagnosing and treating diseases involved in bone development. In preferred embodiments, the present invention is directed to methods for treating, diagnosing and preventing osteoporosis.
    Type: Grant
    Filed: April 5, 2000
    Date of Patent: August 3, 2004
    Assignees: Genome Therapeutics Corporation, Creighton University School of Medicine
    Inventors: John P. Carulli, Randall D. Little, Robert R. Recker, Mark L. Johnson
  • Patent number: 6747137
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Candida albicans that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from fungal infection.
    Type: Grant
    Filed: February 12, 1999
    Date of Patent: June 8, 2004
    Assignee: Genome Therapeutics Corporation
    Inventors: Keith G. Weinstock, David Bush
  • Patent number: 6737519
    Abstract: This invention relates to isolated nucleic acids comprising genes of human chromosome 12q23-qter and the proteins encoded by these genes. Expression vectors and host cells containing such genes or fragments thereof, as well as antibodies to the proteins encoded by these nucleic acids are also included herein.
    Type: Grant
    Filed: July 28, 2000
    Date of Patent: May 18, 2004
    Assignee: Genome Therapeutics Corporation
    Inventors: Tim Keith, Randall Little, Paul Van Eerdewegh, Josèe Dupuis, Richard Del Mastro, Jason Simon, Kristina Allen, Sunil Pandit
  • Patent number: 6699703
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Streptococcus pneumoniae that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
    Type: Grant
    Filed: May 26, 2000
    Date of Patent: March 2, 2004
    Assignee: Genome Therapeutics Corporation
    Inventors: Lynn Doucette-Stamm, David Bush, Qiandong Zeng, Timothy Opperman, Chad Eric Houseweart
  • Patent number: 6683165
    Abstract: This invention relates to isolated nucleic acids comprising genes of human chromosome 20p13-p12 and the proteins encoded by these genes. Expression vectors and host cells containing such genes or fragments thereof, as well as antibodies to the proteins encoded by these nucleic acids are also included herein.
    Type: Grant
    Filed: April 13, 2000
    Date of Patent: January 27, 2004
    Assignee: Genome Therapeutics Corporation
    Inventors: Tim Keith, Randall Little, Paul Van Eerdewegh, Josée Dupuis, Richard Del Mastro, Jason Simon, Kristina Allen, Sunil Pandit
  • Publication number: 20040009583
    Abstract: A microtiter plate having at least one well and a lid having at least one insert which seals and reduces the volume of the well and methods of using the combination of the well and insert are described herein.
    Type: Application
    Filed: February 5, 2003
    Publication date: January 15, 2004
    Applicant: Genome Therapeutics Corporation
    Inventors: James A. Benn, Douglas R. Smith, Joseph D. Michienzi
  • Patent number: 6673910
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Moracella catarrhalis that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
    Type: Grant
    Filed: April 4, 2000
    Date of Patent: January 6, 2004
    Assignee: Genome Therapeutics Corporation
    Inventor: Gary L. Breton
  • Patent number: 6610836
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Klebsiella pneumoniae that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
    Type: Grant
    Filed: January 27, 2000
    Date of Patent: August 26, 2003
    Assignee: Genome Therapeutics Corporation
    Inventors: Gary L. Breton, Mark Osborne
  • Patent number: 6605709
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Proteus fragilis that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
    Type: Grant
    Filed: April 5, 2000
    Date of Patent: August 12, 2003
    Assignee: Genome Therapeutics Corporation
    Inventor: Gary L. Breton
  • Patent number: 6583275
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived Enterococcus faecium that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
    Type: Grant
    Filed: June 30, 1998
    Date of Patent: June 24, 2003
    Assignee: Genome Therapeutics Corporation
    Inventors: Lynn A. Doucette-Stamm, David Bush
  • Patent number: 6583266
    Abstract: Embodiments of the present invention feature nucleic acid and proteins derived from Mycobacterium tuberculosis and leprae. The proteins and nucleic acid of the present invention have applications in diagnostics and therapeutics.
    Type: Grant
    Filed: September 16, 1994
    Date of Patent: June 24, 2003
    Assignee: Genome Therapeutics Corporation
    Inventors: Douglas R. Smith, Jen-i Mao
  • Patent number: 6562958
    Abstract: The invention provides isolated polypeptide and nucleic acid sequences derived from Acinetobacter mirabilis that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
    Type: Grant
    Filed: June 4, 1999
    Date of Patent: May 13, 2003
    Assignee: Genome Therapeutics Corporation
    Inventors: Gary Breton, David Bush